Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
about
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drugApplication of cross-species PET imaging to assess neurotransmitter release in brainToxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literaturePsychedelicsHigh-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.Serotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.5-HT radioligands for human brain imaging with PET and SPECTPreclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.[Near fatal intoxication with the novel psychoactive substance 25C-NBOMe].In vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function micePET tracers for serotonin receptors and their applicationsIdentification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical IntoxicationSynthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.Serotonin and molecular neuroimaging in humans using PET.2C-I-NBOMe, an "N-bomb" that kills with "Smiles". Toxicological and legislative aspects.Current radiosynthesis strategies for 5-HT2A receptor PET tracers.Optimising PET approaches to measuring 5-HT release in human brain.Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.Chemistry and Structure-Activity Relationships of Psychedelics.Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil.Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the Nonhuman Primate BrainDirect comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions.Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150.Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression.Detection of 25C-NBOMe in Three Related Cases.18F-Labelling of electron rich iodonium ylides: application to the radiosynthesis of potential 5-HT2A receptor PET ligands.Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.25C-NBOMe Ingestion.Accelerating preclinical PET-screening: reductive amination with [11C]methoxybenzaldehydes
P2860
Q26822943-66CB3513-A01E-41A0-A1C6-5045405A6684Q26865012-1F9FCABC-F2B7-4B8B-AF7A-21AC1B381F23Q26865329-EF145FF1-4621-4EB8-B5D2-DC545E419C12Q30359998-3B37500D-ECB2-4BAC-90F1-F4E301374BE4Q33829385-1239CE1B-2A38-4E49-A0AC-C0C41F318A8AQ33851479-E14E2584-48D5-4823-917C-67E1DCAEABD4Q34192729-53458B1B-3C22-4B5D-9823-165518DA7175Q34322022-C2E2FEE7-DC67-4CDB-B8CC-AB150A9CEDEEQ34369264-F0E70584-5298-459E-AD22-E64C390EE011Q34396223-08F9E02F-879A-474A-84A0-60407BE08C60Q34406732-553B2368-8CB1-4970-B6BD-7A3C31BFDFF3Q34417353-8733F788-ACC3-420A-9353-2096C8F38CE0Q34545944-09B578AF-7C98-413D-9911-30F1D10F2790Q35068582-6D905872-96A8-4219-831F-78D185756CBFQ35090637-13DD5882-CBD2-4388-80DD-89D850DF13C0Q36062680-B37DC2AB-4432-43F9-A639-495EBDFFE0A6Q36751879-4B47DE8A-811A-41E9-9401-39D895F96D7DQ37380723-4D6A3BF3-4018-4862-B938-E5CD0CA85301Q37672302-8F5FC25F-4FAE-4EC0-8DCA-923C9ED2E403Q37728569-91D43B51-1348-4A0A-9135-EDB96C512E30Q37938794-8CB6B7C2-A577-4585-97A5-6D66F1899D08Q38208426-18FE6DF0-9309-4B80-B6F7-E07F79EA2ECBQ38495731-0157C5E5-47DB-4480-A3EF-7A5502B0847BQ38531787-58776058-42BA-4C7D-8190-C4450888D48AQ38588257-50E1785E-5F6A-44FF-8128-A2B2004B0ADAQ38841130-20C6DB81-BAC6-40A7-BEFD-1F3C7C3AF171Q39093171-57AE8E18-C1F6-4537-B134-097CB9D7D419Q41030351-7C9A0E3E-72C2-4630-9507-2852370EB231Q41595331-940003E2-D321-4EE8-9B8A-4E409FF92E92Q45330207-06A617EB-8AEB-4B82-87FE-0138DAC0B032Q47928428-D702185C-A4FE-4610-B54D-95D4B64C82BDQ48133253-364819B0-55D9-447B-A958-4ED9A3B34B56Q48299643-EBE00F5A-9D24-4277-B806-A098B35A927EQ48326950-3E7ED027-3112-457E-B577-FEC4C2547E2DQ48721685-D6491EDD-B76C-45EB-B95F-CA3851BF92CEQ52096255-4DAA2662-1A79-4EDA-A0A0-8C2E1C001175Q53080749-560BAA41-A399-4DF1-BB95-95F91C12BD9EQ55383928-7102E44C-DDA4-4690-BD22-BD70435D2E77Q57396183-61BD1B2A-F207-42CC-9F99-94224C242268
P2860
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@ast
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@en
Radiosynthesis and in vivo eva ...... ed 11C-phenethylamines as 5-HT
@nl
type
label
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@ast
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@en
Radiosynthesis and in vivo eva ...... ed 11C-phenethylamines as 5-HT
@nl
prefLabel
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@ast
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@en
Radiosynthesis and in vivo eva ...... ed 11C-phenethylamines as 5-HT
@nl
P2093
P2860
P50
P1476
Radiosynthesis and in vivo eva ...... 5-HT (2A) agonist PET tracers.
@en
P2093
Jacob Madsen
James Paine
Martin A Santini
Martin Hansen
Matthias M Herth
Mikael Begtrup
P2860
P2888
P304
P356
10.1007/S00259-010-1686-8
P50
P577
2010-12-21T00:00:00Z